3 studies found for: ((AT13387 AND GIST) OR NCT01245218 OR NCT00878423)
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
AT13387 in Adults With Refractory Solid Tumors
† Study has passed its completion date and status has not been verified in more than two years.